NOMAD POWER SOLUTIONS, INC. Current Liabilities
NOMAD POWER SOLUTIONS, INC. (NMAD) had Current Liabilities of $1.50 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $1.50M.
- 2026-03-31: Liabilities, Current $1.22M.
- 2025-12-31: Liabilities, Current $1.33M.
- 2025-09-30: Liabilities, Current $521.42K.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.50M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.22M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $1.33M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $521.42K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $537.12K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $355.10K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $318.28K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $328.96K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $421.46K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $462.84K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $313.86K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $311.74K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $402.61K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $249.99K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $395.76K 10-K · filed 2024-03-19 | $394.79K 10-K · filed 2023-03-29 |
| 2022-09-30 | $408.33K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $531.54K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $644.59K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $302.93K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $258.70K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $376.33K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $242.40K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $216.52K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $221.46K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $213.97K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $225.32K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $237.90K 10-K · filed 2021-03-26 | |
| 2019-09-30 | $309.31K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $223.03K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $244.81K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $210.91K 10-K · filed 2020-03-25 | |
| 2018-09-30 | $459.03K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $338.31K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $238.68K 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $373.02K 10-K · filed 2019-03-25 | |
| 2017-09-30 | $256.21K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $241.81K 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $254.46K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $218.65K 10-K · filed 2018-03-23 | |
| 2016-09-30 | $195.58K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $139.56K 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $192.62K 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $285.64K 10-K · filed 2017-03-29 | |
| 2015-09-30 | $222.18K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $198.19K 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $254.18K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $273.44K 10-K · filed 2016-03-28 | |
| 2014-09-30 | $402.32K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $327.17K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $284.21K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $321.77K 10-K · filed 2015-03-27 | |
| 2013-09-30 | $293.50K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $266.01K 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $270.14K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $261.15K 10-K · filed 2014-03-21 | |
| 2012-09-30 | $246.47K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $351.32K 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $467.12K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $350.75K 10-K · filed 2013-03-15 | |
| 2011-09-30 | $362.39K 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $337.07K 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $195.06K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |